TP53 and cervical carcinoma: In summary, 125I particles inhibited the invasive and migratory capabilities of cervical cancer by upregulating the HSF1/PU.1/SYK signaling pathway and enhancing the ROS/USP7/P53-mediated apoptotic response (Fig. 7).